EP1124948A1 - Procede de creation d'une banque de genes - Google Patents
Procede de creation d'une banque de genesInfo
- Publication number
- EP1124948A1 EP1124948A1 EP99948722A EP99948722A EP1124948A1 EP 1124948 A1 EP1124948 A1 EP 1124948A1 EP 99948722 A EP99948722 A EP 99948722A EP 99948722 A EP99948722 A EP 99948722A EP 1124948 A1 EP1124948 A1 EP 1124948A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- organisms
- pool
- interest
- dna
- enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 78
- 238000000034 method Methods 0.000 title claims abstract description 74
- 108020004414 DNA Proteins 0.000 claims abstract description 69
- 230000000694 effects Effects 0.000 claims abstract description 49
- 230000007613 environmental effect Effects 0.000 claims abstract description 38
- 229920001184 polypeptide Polymers 0.000 claims abstract description 31
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 31
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 31
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 15
- 102000004190 Enzymes Human genes 0.000 claims description 42
- 108090000790 Enzymes Proteins 0.000 claims description 42
- 229940088598 enzyme Drugs 0.000 claims description 42
- 239000000758 substrate Substances 0.000 claims description 36
- 238000012216 screening Methods 0.000 claims description 31
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 23
- 244000005700 microbiome Species 0.000 claims description 19
- 108010065511 Amylases Proteins 0.000 claims description 15
- 102000013142 Amylases Human genes 0.000 claims description 15
- 241000238631 Hexapoda Species 0.000 claims description 15
- 241001465754 Metazoa Species 0.000 claims description 15
- 235000019418 amylase Nutrition 0.000 claims description 15
- 239000004382 Amylase Substances 0.000 claims description 12
- 108091005804 Peptidases Proteins 0.000 claims description 10
- 108010059820 Polygalacturonase Proteins 0.000 claims description 10
- 239000004365 Protease Substances 0.000 claims description 9
- 101710152845 Arabinogalactan endo-beta-1,4-galactanase Proteins 0.000 claims description 8
- 108010059892 Cellulase Proteins 0.000 claims description 8
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 claims description 8
- 101710147028 Endo-beta-1,4-galactanase Proteins 0.000 claims description 8
- 229940106157 cellulase Drugs 0.000 claims description 8
- 108010093305 exopolygalacturonase Proteins 0.000 claims description 7
- 239000001814 pectin Substances 0.000 claims description 7
- 229920001277 pectin Polymers 0.000 claims description 7
- 210000004767 rumen Anatomy 0.000 claims description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- 241000256602 Isoptera Species 0.000 claims description 6
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 6
- -1 beta-glucoamylase Proteins 0.000 claims description 6
- 235000010987 pectin Nutrition 0.000 claims description 6
- 229920000856 Amylose Polymers 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims description 5
- 108010005774 beta-Galactosidase Proteins 0.000 claims description 5
- 241000254173 Coleoptera Species 0.000 claims description 4
- 241000255777 Lepidoptera Species 0.000 claims description 4
- 108090000854 Oxidoreductases Proteins 0.000 claims description 4
- 102000004316 Oxidoreductases Human genes 0.000 claims description 4
- 239000001913 cellulose Substances 0.000 claims description 4
- 229920002678 cellulose Polymers 0.000 claims description 4
- 210000002784 stomach Anatomy 0.000 claims description 4
- 239000003053 toxin Substances 0.000 claims description 4
- 231100000765 toxin Toxicity 0.000 claims description 4
- 241000218473 Agrotis Species 0.000 claims description 3
- 102100026189 Beta-galactosidase Human genes 0.000 claims description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
- 241000255925 Diptera Species 0.000 claims description 3
- 108090000371 Esterases Proteins 0.000 claims description 3
- 241000233866 Fungi Species 0.000 claims description 3
- 241000254099 Melolontha melolontha Species 0.000 claims description 3
- 241000259850 Neotermes castaneus Species 0.000 claims description 3
- 241000333690 Tineola bisselliella Species 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 108010002430 hemicellulase Proteins 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 241000203069 Archaea Species 0.000 claims description 2
- 241000195493 Cryptophyta Species 0.000 claims description 2
- 108010015776 Glucose oxidase Proteins 0.000 claims description 2
- 239000004366 Glucose oxidase Substances 0.000 claims description 2
- 102000004157 Hydrolases Human genes 0.000 claims description 2
- 108090000604 Hydrolases Proteins 0.000 claims description 2
- 108010029541 Laccase Proteins 0.000 claims description 2
- 108010059881 Lactase Proteins 0.000 claims description 2
- 102000003960 Ligases Human genes 0.000 claims description 2
- 108090000364 Ligases Proteins 0.000 claims description 2
- 108090001060 Lipase Proteins 0.000 claims description 2
- 102000004882 Lipase Human genes 0.000 claims description 2
- 239000004367 Lipase Substances 0.000 claims description 2
- 108090000856 Lyases Proteins 0.000 claims description 2
- 102000004317 Lyases Human genes 0.000 claims description 2
- 102000003992 Peroxidases Human genes 0.000 claims description 2
- 102000004357 Transferases Human genes 0.000 claims description 2
- 108090000992 Transferases Proteins 0.000 claims description 2
- 229940116332 glucose oxidase Drugs 0.000 claims description 2
- 235000019420 glucose oxidase Nutrition 0.000 claims description 2
- 229940059442 hemicellulase Drugs 0.000 claims description 2
- 239000005556 hormone Substances 0.000 claims description 2
- 229940088597 hormone Drugs 0.000 claims description 2
- 229940116108 lactase Drugs 0.000 claims description 2
- 235000019421 lipase Nutrition 0.000 claims description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims 1
- 229930182830 galactose Natural products 0.000 claims 1
- 239000000463 material Substances 0.000 description 29
- 238000003556 assay Methods 0.000 description 22
- 238000002360 preparation method Methods 0.000 description 20
- 239000002299 complementary DNA Substances 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 16
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 15
- 102000004169 proteins and genes Human genes 0.000 description 13
- 241000196324 Embryophyta Species 0.000 description 12
- 239000002131 composite material Substances 0.000 description 10
- 239000000203 mixture Substances 0.000 description 9
- 239000002689 soil Substances 0.000 description 9
- 238000001400 expression cloning Methods 0.000 description 7
- 239000008187 granular material Substances 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 238000012552 review Methods 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 210000002421 cell wall Anatomy 0.000 description 6
- 230000000593 degrading effect Effects 0.000 description 6
- 108020004999 messenger RNA Proteins 0.000 description 6
- 238000002224 dissection Methods 0.000 description 5
- 235000019419 proteases Nutrition 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 102000035195 Peptidases Human genes 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 125000001475 halogen functional group Chemical group 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 108010084185 Cellulases Proteins 0.000 description 3
- 102000005575 Cellulases Human genes 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 239000011543 agarose gel Substances 0.000 description 3
- 229940025131 amylases Drugs 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- NTHXOOBQLCIOLC-UHFFFAOYSA-N iohexol Chemical compound OCC(O)CN(C(=O)C)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I NTHXOOBQLCIOLC-UHFFFAOYSA-N 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 239000004753 textile Substances 0.000 description 3
- 108700012359 toxins Proteins 0.000 description 3
- 229920000936 Agarose Polymers 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 102000005936 beta-Galactosidase Human genes 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000010287 polarization Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 229920001221 xylan Polymers 0.000 description 2
- NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 1
- 108010011619 6-Phytase Proteins 0.000 description 1
- 108010013043 Acetylesterase Proteins 0.000 description 1
- 240000008791 Antiaris toxicaria Species 0.000 description 1
- 102100032487 Beta-mannosidase Human genes 0.000 description 1
- 108010008885 Cellulose 1,4-beta-Cellobiosidase Proteins 0.000 description 1
- 241000218631 Coniferophyta Species 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 101710200526 DNA polymerase 2 Proteins 0.000 description 1
- 101001096557 Dickeya dadantii (strain 3937) Rhamnogalacturonate lyase Proteins 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 102000004195 Isomerases Human genes 0.000 description 1
- 108090000769 Isomerases Proteins 0.000 description 1
- 241000209510 Liliopsida Species 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 241000254071 Melolontha Species 0.000 description 1
- 102100036617 Monoacylglycerol lipase ABHD2 Human genes 0.000 description 1
- 108010029182 Pectin lyase Proteins 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229920002000 Xyloglucan Polymers 0.000 description 1
- 108010084455 Zeocin Proteins 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 102000005840 alpha-Galactosidase Human genes 0.000 description 1
- 108010030291 alpha-Galactosidase Proteins 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 108010019077 beta-Amylase Proteins 0.000 description 1
- 108010047754 beta-Glucosidase Proteins 0.000 description 1
- 102000006995 beta-Glucosidase Human genes 0.000 description 1
- 108010055059 beta-Mannosidase Proteins 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000000853 biopesticidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 239000004464 cereal grain Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- YTRQFSDWAXHJCC-UHFFFAOYSA-N chloroform;phenol Chemical compound ClC(Cl)Cl.OC1=CC=CC=C1 YTRQFSDWAXHJCC-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001418 larval effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000007431 microscopic evaluation Methods 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 108020004410 pectinesterase Proteins 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- CWCMIVBLVUHDHK-ZSNHEYEWSA-N phleomycin D1 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC[C@@H](N=1)C=1SC=C(N=1)C(=O)NCCCCNC(N)=N)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C CWCMIVBLVUHDHK-ZSNHEYEWSA-N 0.000 description 1
- 229940085127 phytase Drugs 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000007423 screening assay Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000010865 sewage Substances 0.000 description 1
- 239000010802 sludge Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 150000004823 xylans Chemical class 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups
Definitions
- the present invention relates to a method of generating a gene library from an environmental pool of organisms, which gene library is enriched in DNA encoding a polypeptide with an activity of interest.
- WO 93/11249 Novartis A/S
- the technique disclosed in WO 93/11249 comprises a method of screening for a DNA sequence in a DNA library prepared from an organism suspected of producing genes encoding polypeptides with activities of interest. Such a library has traditionally been made on DNA isolated from a single known microorganism.
- a compartmentalization method of screening microorganisms having a selectable characteristic has previously been devised in WO 97/37036, and a process for forming a normalized genomic DNA library from an environmental sample is described in WO 97/37036.
- the invention provides a method for generating a gene library from an environmental pool of organisms, which gene library is enriched in DNA encoding a polypeptide with an activity of interest, which method comprises : a) subjecting the environmental pool of organisms to cultivation in a medium and/or under conditions suitable for enriching said pool of organisms in organisms harbouring said DNA; and b) preparing a gene library from the resulting enriched pool of organisms.
- the invention also provides a method of selecting a DNA sequence of interest from an environmental pool of organisms, which method comprises :
- step c) a) subjecting the environmental pool of organisms to cultivation in a medium and/or conditions suitable for enriching said pool of organisms in organisms harbouring said DNA sequence; b) producing gene libraries from the resulting enriched pool of organisms; c) screening the libraries for DNA containing the desired gene; and d) selecting the DNA sequence of interest resulting from the screening of step c) .
- the invention relates to a gene library prepared from an enriched environmental pool of organisms enriched in DNA encoding a polypeptide with an activity of interest.
- an environmental pool of organisms means a environmental sample comprising microorganisms and cells from higher animals harboring DNA encoding a polypeptide with an activity of interest .
- the environmental sample may for instance be an environmental sample of soil or plant material, animal or insect dung, insect gut, animal stomach, a marine sample of sea or lake water, sewage, waste water, a sample of sludge or sediment, etc., comprising one or, as in most case, a vast number of different microorganisms or living cells.
- step a) the sample as such is cultivated without any need for further purification.
- the gene library prepared in step b) may be prepared by any suitable technique known in the art, non- limiting examples of which are described in Example 3 and 4.
- the advantage presented by the present screening method is primarily that the rate at which novel genes may be isolated and, consequently, novel products be developed may be greatly increased. Furthermore, the method permits screening for multiple polypeptides activities and may even result in the isolation of several different genes coding for the same type of polypeptides. By use of the invention it is possible to exploit enriched cultures for detecting novel enzymes, and other polypeptides with an activity of interest.
- the method of the invention comprises subjection the environmental pool of organisms to cultivation in a medium, which contains a substrate for the polypeptide with the desired activity.
- a substrate for the polypeptide with the desired activity may be used.
- a DNA encoding a polypeptide with an activity of interest such as a pectinase enzyme may be selected as a gene product on a substrate as pectin.
- the substrate constitutes the carbon source and/or nitrogen source of the medium.
- the substrate comprises pectin, amylose, cellulose, galactan, xylan, arabinan, mannan, lipid or hemicellulose or a combination thereof.
- the enrichment is achieved by one or more growth conditions.
- the growth conditions comprise pH and temperature.
- the growth conditions of step a) used for achieving the enrichment comprises any pH range i.e. 0-12, preferably of about 6-9, in particular 9-12, at any temperature range i.e. 0-120°C, preferably about 25-30°, preferably 30-50°, most preferred 50- 70°C.
- the environmental pool of microorganisms is isolated from an animal stomach or an insect gut .
- the pool of microorganisms is isolated from a cow's rumen.
- the guts of the larvae belonging to the orders of insects known to be sensitive to the Bt toxins comprise environmental pools of a high alkaline nature (approx pH 10) .
- Such insect orders are especially Isoptera, Lepidoptera, Coleoptera and Diptera. Consequently in a preferred embodiment, the pool of microorganisms is isolated from the gut of an insect of the Isoptera, Lepidoptera, Coleoptera, or Diptera families.
- the pool of microorganisms is isolated from the gut of insects selected from the group consisting of Agrotis, Neotermes castaneus, Tineola bisselliella, and Melolontha vulgaris .
- the pool of microorganisms is enriched by supplying feed to the animal or insect, which comprises a substrate for the polypeptide with an activity of interest .
- DNA encoding a polypeptide with an activity of interest include among others enzymatic activity and anti-microbial activity.
- the gene libraries are enriched in DNA encoding an enzyme activity of interest.
- the activity of interest is an enzymatic activity, such as an activity selected from the group comprising of phosphatases oxidoreductases (E.C. 1), transferases (E.C. 2); hydrolases
- E.C. 3 such as esterases (E.C. 3.1), in particular upases and phytase; such as glucosidases (E.C. 3.2), in particular xylanase, cellulases, hemicellulases, and amylase, such as peptidases (E.C. 3.4), in particular proteases; lyases (E.C. 4) ; isomerases (E.C. 5) ; ligases (E.C. 6) .
- esterases E.C. 3.1
- upases and phytase such as glucosidases (E.C. 3.2), in particular xylanase, cellulases, hemicellulases, and amylase, such as peptidases (E.C. 3.4), in particular proteases; lyases (E.C. 4) ; isomerases (E.C. 5) ; ligases (
- the enzyme of interest comprises a protease, lipase, beta-galactosidase, lactase, polygalacturonase, beta-glucoamylase, esterase, hemicellulase, peroxidase, oxidase, laccase or glucose oxidase .
- the enzymes obtained in the method is an amylase, in particular an ⁇ -amylase or a ⁇ -amylase, an arabinanase, an arabinofuranosidase, a galactanase, an ⁇ - galactosidase, a ⁇ -galactosidase, a polygalacturonase, a pectin methyl esterase, a rhamnogalacturonase, a rhamnogalacturon acetyl esterase, a pectin lyase, a xylanase, a cellulase, a ⁇ - glucosidase, a cellobiohydrolase, a xylosidase, a mannanase, and/or a glucuronisidase.
- an amylase in particular an ⁇ -amylase or a ⁇ -amylase
- the environmental pool of organisms containing DNA encoding a polypeptide with an activity of interest are typically microorganisms such as Eubacteria, Archaebacteria, fungi, algae and/or protozoa.
- the polypeptide may be an enzyme of interest obtained from any known organism.
- the enzyme may be obtained from microorganism, in particular from a bacteria, from a filamentous fungus or a yeast .
- the organisms are enriched cultures meaning that the cultures are selected on a specific substrate from which other organisms are not able to grow or having a reduced growth.
- Step a) and b) are as described above.
- step c) clones found to comprise a DNA sequence originated from the prepared gene library in step b) may be screened for any activity of interest. Examples of such activities include enzymatic activity, anti-microbial activity or biological activities.
- step c) gene libraries are screened for genomic DNA containing the desired gene, and in step d) , the DNA sequence of interest are selected from the screening of step c) .
- Step c) and d) may be performed by standard methods known in the art .
- polypeptide with the activity of interest may then be tested for a desired performance under specific conditions and/or in combination with e . g. chemical compounds or agents.
- the gene libraries may be screened according to the method of the invention for a polypeptide with an activity of interest e.g. a specific activity, and/or a specific property of interest such as thermostability, high pH tolerance, wash performance, textile dyeing, hair dyeing or bleaching properties, a effect in feed or food ect .
- an activity of interest e.g. a specific activity, and/or a specific property of interest such as thermostability, high pH tolerance, wash performance, textile dyeing, hair dyeing or bleaching properties, a effect in feed or food ect .
- the appropriate assay for testing for a desired activity and/or property well be known to the skilled person.
- the gene library comprises an enzyme-encoding gene of interest, and the gene library is screened for enzymes under conditions which the enzyme is active.
- the library may be screened for enzymes at e.g. high temperatures such as 60-110°C and high pH such as 10-12 e.g. in cases where it is desired to isolate a DNA sequence encoding an alkaline enzyme with a relatively high thermostability.
- pH can be in any range e.g. of from about 0 to about 12, and the temperature in any range e.g. of from about 5 to about 110°C, preferably of from about 60 to about 90°C.
- the gene library comprises a polypeptide with an activity of an enzyme, a hormone or a toxin.
- the gene library comprises an enzyme activity of interest as described above.
- the respective liquid enrichment media were prepared by mixing 100 ml of A+B+C+ 100 ml pectin or cellulose or starch and 600 ml sterile water.
- the enrichments were used for preparation of a mixed enrichment library. 50 ml of each selected enrichment culture were centrifuged and the combined cell pellets used for gene library construction. The clones were obtained by screening of the library, distributed on amylase, arabinase, xylanase, galactanase and pectinase activity.
- the cells from the cultures were washed with 0.9% NaCl and pooled into one tube .
- DNA was extracted using method described by Pitcher et al . (Pitcher, D. G. , saunders,N.A. ,Owen;R.J. (1989) . Rapid extraction of bacterial genomic DNA with guanidium thiocyanate. Lett .Appl.Microbiol. , 8,151-156.). The DNA extraction recovered 170 ⁇ g high molecular weight DNA.
- the DNA were trimmed to make blunt ends .
- the reaction mixture was incubated at room temp, for 30 min, and 200 ⁇ l 1 x TE, pH 8.0, were added.
- the mixture was extracted with 1 x phenol-chloroform, 1 x CIA, 0.1 vols 3 M NaOAc was added, pH 5.2, 2 vols 96 % EtOH were added, ppt on ice for 30 min, or overnight at -20°C and resupended in 16 ⁇ l H 2 0.
- the end trimmed DNA was ligated into a fresh Eco RV digested pZero (Invitrogen) .
- the ligation mixture was transformed into DH10B E.coli cells by electroporation and frozen in aliqouts corresponding to 300 zeocin resistant colonies.
- the frozen alliqouts constitute the library no. 1.
- the DNA was partially digested with the restriction enzyme Sau3A and the DNA was size-fractionated on a 1% agarose gel (Maniatis et al . ) .
- the agarose containing the DNA corresponding to 3kb and upwards in size was cut from the agarose gel and the DNA was concentrated by further electrophoresis into a 1.2% agarose gel.
- the DNA was isolated from the agarose piece using the GFX kit (Pharmacia) .
- the Sau3A digested DNA was ligated into a fresh BamHI digested pZero-2 (Invitrogen) .
- the ligation mixture was transformed into DH10B E. coli cells by electroporation and frozen in aliqouts corresponding to 300 kanamycin resistant colonies. The frozen aliqouts constitute the library no. 2.
- the assay contains the following reagents:
- 384 well In each well were 60 ⁇ l ( ⁇ 25ml/microplate) used as standard volume .
- the cells were grown for 65 hours, and thereafter 50 ⁇ l of cells were pipetted into 150 ⁇ l assay substrate for 96 well plates or
- Arabinase assay 20 contains the following reagents:
- 384 well In each well were 60 ⁇ l used as standard volume.
- the cells were grown for 65 hours, and thereafter 50 ⁇ l of cells were pipetted into 150 ⁇ l assay substrate for 96 well plates or
- the assay contains the following reagents
- the cells were grown for 65 hours, and thereafter 50 ⁇ l of cells were pipetted into 150 ⁇ l assay substrate for 96 well plates or 20 ⁇ l into 60 ⁇ l assay substrate for 384 well plates. The assay- plates were incubated over night at 50°C in a bag. Positive
- Numbered black microtiter plates were filled with 150ml assay 20 mix* as described below using a Multidrop instrument. Subsequently, 50ml of cells were pipetted automatically into the assay plates using a Plate Mate pipetting station. Plates were left at room temperature (in the dark) for approximately 150-180 min., and subsequently read by a FPM-2 fluorescence 25 polarization reader using excitation-filter 485/22 and emission-filter 530/30. Positive clones were scored as a lowering of the polarization value which typically was from approximately 90mP to 50-70mP.
- the assay contains the following reagents
- 96 well In each well were 150 ⁇ l used as standard volume. 384 well: In each well were 60 ⁇ l used as standard volume. The cells were grown for 65 hours, and thereafter 50 ⁇ l of cells were pipetted into 150 ⁇ l assay substrate for 96 well plates or 20 ⁇ l into 60 ⁇ l assay substrate for 384 well plates. The assay- plates were incubated over night at 50°C in a bag. Positive reactions were observed as blue colour in the well.
- Gene Library no . 2 was screened on LB agar plates containing 25 ⁇ g/ml kanamycin as the antibiotic selection marker and 0.03% AZCL-xyloglucan + 0.03% AZCL-galactan + 0.03% AZCL-amylose as enzyme substrates at 37°C. The formation of a blue halo around the colony indicates enzyme activity. The colony was restreaked onto LB plates containing each of the AZCl substrates to identify the enzyme activity. Three amylase positive clones were discovered.
- Termite larvae (Neotermes castaneus) were acquired from BAM (Bundesweg fur Materialtechnisch für -Pr ⁇ fung,
- Enrichment procedure The larvae were subsequently reared and fed on non-sterile plant materials, originating either from gymnosperms or angiosperms (monocot or dicot) , enabling enzymatic (endo- and exo-) digestion through plant cell wall degrading enzyme activity.
- D ⁇ A preparation D ⁇ A preparations were made from such composite gut materials using commercially available D ⁇ A kits (FAST D ⁇ A- KitH, Bio 101 Inc, 1070 Joshua Way, California, US) . This high quality D ⁇ A material was used to prepare a genomic library, e.g. following a protocol as follows: digestion by Sau3A, fractionation and selection of specific size range, cloning in the Bacteriphage Lambda-Zap-Express (AH Diagnostic, originating from Stratagene, US) . Full protocols are given by the kit- manufacturers .
- RNA preparation Total RNA preparations were made from said composite gut materials using commercially available RNA kits and public protocols, as e.g.
- Identified hits more than 200 cellulase active clones were finally identified on HE Azur cross linked blue granule substrates from MegaZyme. PCR made directly from individual colonies (PCR procedures as indicated in relevant text books, using e.g. the polymerases available from Advanced Biotechnologies, Surrey, UK) was used to differentiate and group the hits. The primers used were based on recognition and amplification of the sense and antisense cDNA cloning plasmid pYes-2 (commercially available from Invitrogene, US) . At least four different sized functional genes were hereby identified.
- Enrichment procedure The larvae were subsequently reared and fed on non-sterile protein-rich materials (as e.g. feather, hair and wool) . Further enrichment through dissection (optional) : The larvae were decapitated under a stereoscopic microscope after which the gut (including gut content) was selected and pooled together from several animals
- DNA preparation DNA preps were made from such composite gut materials using commercially available DNA kits. This high quality DNA material was used to prepare a genomic library.
- RNA preparation Total RNA preps were made from said composite gut material using commercially available RNA kits and protocols. The mRNA fraction was subsequently harvested. Based on this the corresponding cDNA prep was made. This was used to construct a cDNA library, representing the expressed proteins at the given time. Screening of the ⁇ enomic library enriched for DNA from those organisms specifically benefiting from the feeding conditions of the larvae under preparation: a plaque screening procedure was adapted to enzyme substrate holding plates, indicating which phages were holding an insert of a full functional gene encoding an enzyme with the protease activity of interest. Screening of the cDNA library enriched for high expression of proteins useful to degrade the feed given to the larvae : the protocol for expression cloning, as given in H.Dalb ⁇ ge, 1997 (FEMS Microbiology Reviews 21, 29-42) .
- protease active clones could be identified by screening on substrate plates with AZCL-casein blue granules from MegaZyme. The protease hits could be further subdivided according to which types of protein bonds they specifically degrade.
- Larvae of Melolontha vulgaris (Coleoptera) were collected from Danish habitats (Zealand) where the soil is rich in a very varied composition of plant debris. The larvae of this species are free living in soil, feeding for up to 3 years on plant materials
- Enrichment procedure The larvae were subsequently reared and fed non-sterile non-specified plant debris of a very broad taxonomic composition. Further enrichment through dissection (optional) : The larvae were decapitated under a stereoscopic microscope after which the guts (including gut content) were selected and pooled together from several animals.
- DNA preparation DNA preps were made from such composite gut material using commercially available DNA kits. This high quality DNA material was used to prepare a genomic library.
- RNA preparation Total RNA preps were made from said composite gut material using commercially available RNA kits and protocols. The mRNA fraction was subsequently harvested. Based on this, the corresponding cDNA prep was made. This was used to construct a cDNA library, representing the expressed proteins at the given time.
- a plaque screening procedure was adapted to enzyme substrate holding plates, indicating which phages were holding a (functional) gene insert encoding an enzyme with the plant cell wall degrading activity of interest .
- Enrichment procedure The larvae were subsequently reared and fed non-sterile starch rich materials. Further enrichment through dissection (optional) the larvae were decapitated under a stereoscopic microscope after which the guts (including gut content) were selected and pooled together from several animals .
- DNA preparation DNA preps were made from such composite gut material using commercially available DNA kits. This high quality DNA material was used to prepare a genomic library.
- RNA preparation Total RNA preps were made from the composite gut material using commercially available RNA kits and protocols. The mRNA fraction was subsequently harvested. Based on this fraction the corresponding cDNA prep was made. This was used to construct a cDNA library, representing the expressed proteins at the given time.
- a plaque screening procedure was adapted to enzyme substrate holding plates, indicating which phages were holding an insert of a functional gene, encoding an enzyme with a plant cell wall degrading activity of interest.
- Enrichment procedure The cow was in the weeks prior to the sampling fed material of specific composition e.g. hey to enrich for cellulase and other plant cell wall degrading enzymes, cereal grains to enrich for amylase activity and soy to enrich for protease activities.
- specific composition e.g. hey to enrich for cellulase and other plant cell wall degrading enzymes, cereal grains to enrich for amylase activity and soy to enrich for protease activities.
- DNA preparation DNA preps were made from such composite rumen material using commercially available DNA kits. This high quality DNA material was used to prepare a genomic library.
- RNA preparation Total RNA preps were made from the composite rumen material using commercially available RNA kits and protocols. The mRNA fraction was subsequently harvested. Based on this the corresponding cDNA prep was made. This was used to construct a cDNA library, representing the expressed proteins at the given time. Screening of the genomic library enriched for DNA from those organisms specifically benefitting from the feeding conditions of the larvae under preparation: a plaque screening procedure was adapted to be made on enzyme substrate holding plates, indicating which phages were holding an insert of a full functional gene, encoding an enzyme with the activity of interest .
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Computational Biology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
L'invention concerne un procédé de création d'une banque de gènes à partir d'un groupe d'organismes prélevés dans l'environnement. Cette banque de gènes est enrichie en ADN codant pour un polypeptide présentant une activité d'intérêt. L'invention concerne également un procédé de sélection d'une séquence d'ADN d'intérêt à partir d'un groupe d'organismes prélevés dans l'environnement et une banque de gènes obtenue à partir d'un groupe d'organismes prélevés dans l'environnement enrichis avec un ADN codant pour un polypeptide doté d'une activité d'intérêt.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK138898 | 1998-10-28 | ||
DKPA199801388 | 1998-10-28 | ||
PCT/DK1999/000553 WO2000024882A1 (fr) | 1998-10-28 | 1999-10-14 | Procede de creation d'une banque de genes |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1124948A1 true EP1124948A1 (fr) | 2001-08-22 |
Family
ID=8104318
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP99948722A Withdrawn EP1124948A1 (fr) | 1998-10-28 | 1999-10-14 | Procede de creation d'une banque de genes |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1124948A1 (fr) |
JP (1) | JP2002528075A (fr) |
CN (1) | CN1325445A (fr) |
AU (1) | AU6188699A (fr) |
CA (1) | CA2343878A1 (fr) |
WO (1) | WO2000024882A1 (fr) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002102820A1 (fr) | 2001-06-20 | 2002-12-27 | Nuevolution A/S | Derives nucleosidiques pour elaboration de bibliotheque combinatoire |
ATE414769T1 (de) | 2002-03-15 | 2008-12-15 | Nuevolution As | Eine verbesserte methode zur synthese von matritzenabhängigen molekülen |
AU2003247266A1 (en) | 2002-08-01 | 2004-02-23 | Nuevolution A/S | Multi-step synthesis of templated molecules |
ES2640279T3 (es) | 2002-10-30 | 2017-11-02 | Nuevolution A/S | Procedimiento para la síntesis de un complejo bifuncional |
EP1756277B1 (fr) | 2002-12-19 | 2009-12-02 | Nuevolution A/S | Procedes de synthese guidee a fonction et structure quasi-selectives |
US20070026397A1 (en) | 2003-02-21 | 2007-02-01 | Nuevolution A/S | Method for producing second-generation library |
EP1670939B1 (fr) | 2003-09-18 | 2009-11-04 | Nuevolution A/S | Procede permettant d'obtenir des informations structurelles concernant une molecule codee et procede permettant de selectionner des composes |
DE10360805A1 (de) * | 2003-12-23 | 2005-07-28 | Henkel Kgaa | Neue Alkalische Protease und Wasch- und Reinigungsmittel, enthaltend diese neue Alkalische Protease |
EP1957644B1 (fr) | 2005-12-01 | 2010-12-01 | Nuevolution A/S | Procedes de codage enzymatique destines a la synthese efficace de bibliotheques importantes |
DE102007032111B4 (de) | 2007-07-09 | 2017-07-20 | Henkel Ag & Co. Kgaa | Neue Proteasen und Wasch- und Reinigungsmittel enthaltend diese Proteasen |
DE102007033104A1 (de) | 2007-07-13 | 2009-01-15 | Henkel Ag & Co. Kgaa | Mittel enthaltend Proteasen aus Stenotrophomonas maltophilia |
DE102007036756A1 (de) | 2007-08-03 | 2009-02-05 | Henkel Ag & Co. Kgaa | Neue Proteasen und Wasch- und Reinigungsmittel, enthaltend diese neuen Proteasen |
DE102007038031A1 (de) | 2007-08-10 | 2009-06-04 | Henkel Ag & Co. Kgaa | Mittel enthaltend Proteasen |
DE102008017103A1 (de) | 2008-04-02 | 2009-10-08 | Henkel Ag & Co. Kgaa | Wasch- und Reinigungsmittel enthaltend Proteasen aus Xanthomonas |
WO2011127933A1 (fr) | 2010-04-16 | 2011-10-20 | Nuevolution A/S | Complexes bifonctionnels et procédés de fabrication et d'utilisation de tels complexes |
KR20200123144A (ko) * | 2018-02-22 | 2020-10-28 | 지머젠 인코포레이티드 | 바실러스가 농축된 게놈 라이브러리를 생성하고 새로운 cry 독소를 동정하기 위한 방법 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX9206979A (es) * | 1991-12-04 | 1993-07-01 | Novo Nordisk As | Metodo de clonacion de proteinas en levaduras |
US5763239A (en) * | 1996-06-18 | 1998-06-09 | Diversa Corporation | Production and use of normalized DNA libraries |
-
1999
- 1999-10-14 CN CN99812823A patent/CN1325445A/zh active Pending
- 1999-10-14 CA CA002343878A patent/CA2343878A1/fr not_active Abandoned
- 1999-10-14 WO PCT/DK1999/000553 patent/WO2000024882A1/fr active Application Filing
- 1999-10-14 AU AU61886/99A patent/AU6188699A/en not_active Abandoned
- 1999-10-14 JP JP2000578436A patent/JP2002528075A/ja active Pending
- 1999-10-14 EP EP99948722A patent/EP1124948A1/fr not_active Withdrawn
Non-Patent Citations (7)
Also Published As
Publication number | Publication date |
---|---|
CA2343878A1 (fr) | 2000-05-04 |
AU6188699A (en) | 2000-05-15 |
CN1325445A (zh) | 2001-12-05 |
WO2000024882A1 (fr) | 2000-05-04 |
JP2002528075A (ja) | 2002-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Berini et al. | Metagenomics: novel enzymes from non-culturable microbes | |
WO2000024882A1 (fr) | Procede de creation d'une banque de genes | |
Vester et al. | Improved cultivation and metagenomics as new tools for bioprospecting in cold environments | |
Taupp et al. | The art and design of functional metagenomic screens | |
CA2232709C (fr) | Procede d'isolement de sequences de gene de xylanase dans l'adn du sol, compositions utiles a ce procede et compositions ainsi obtenues | |
US6270968B1 (en) | Method of providing a hybrid polypeptide exhibiting an activity of interest | |
JPH02501266A (ja) | 形質転換された乳酸菌 | |
KR20020026456A (ko) | 사상균에서 발현된 dna 라이브러리의 고산출량 스크리닝 | |
EP1766040B1 (fr) | Methodes permettant de transformer et de cribler l'expression de cellules de champignons filamenteux au moyen d'une bibliotheque d'adn | |
CA2090549C (fr) | Expression d'une proteine de surface d'origine bacterienne | |
JPH08500733A (ja) | グルコースの存在下で活性的な真菌プロモーター | |
ES2328011T3 (es) | Selecion de alto rendimiento de bibliotecas de adn expresadas en hongos filamentosos. | |
JP2002528075A5 (fr) | ||
US6723504B1 (en) | Method for generating a gene library | |
Vionis et al. | Production and processing of a 59-kilodalton exochitinase during growth of Streptomyces lividans carrying pCHIO12 in soil microcosms amended with crab or fungal chitin | |
Andersson et al. | Analysis of chitinase expression in the crayfish plague fungus Aphanomyces astaci | |
Do Nascimento et al. | A novel strain of Streptomyces malaysiensis isolated from Brazilian soil produces high endo-β-1, 4-xylanase titres | |
Techapun et al. | Production of a cellulase-free xylanase from agricultural waste materials by a thermotolerant Streptomyces sp. | |
Ye et al. | Isolation of starch and protein degrading strain Bacillus subtilis FYZ1-3 from tobacco waste and genomic analysis of its tolerance to nicotine and inhibition of fungal growth | |
US8440400B2 (en) | Process for amplifying DNA in cells | |
KR100526662B1 (ko) | 자일라나제를 코딩하는 유전자와 그 형질전환체를 이용하여 생산된 재조합 자일라나제 | |
e Oliveira et al. | Production and characterization of endoglucanase secreted by Streptomyces capoamus isolated from Caatinga | |
EP1278833A2 (fr) | Methode de production de bibliotheques genomiques et bibliotheques genomiques obtenues | |
CN106167802A (zh) | 一种新型整合子In1290 | |
KR20180061488A (ko) | 바실러스 세레우스 포자에 특이적인 결합을 보이는 박테리오파지 유래 포자 결합 도메인 및 이 도메인을 이용한 검출용 매개체 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20010528 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
17Q | First examination report despatched |
Effective date: 20050309 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20081126 |